Back to results
US 2022/0031860 A1Published application
Antibodies modified for transglutaminase conjugation, conjugates thereof, and methods and uses
AssigneeBristol-Myers Squibb Company
InventorsPavel STROP, Chetana RAO-NAIK, Xiaodi DENG, Paul O. SHEPPARD, Sean Matthew WEST, Jason Michael HOGAN, Sayumi YAMAZOE
Life of this patent
Estimating the term…
Abstract
Antibodies are modified by replacing amino acids in the heavy chain CH1, CH2, or CH3 or light chain constant region with selected replacement glutamine-containing sequences to render them amenable to conjugation by the enzyme transglutaminase.
Claims24
A full-length IgG antibody, having a modification selected from the group consisting of:
- (i) replacement of the amino acids at EU 131 through 135 of a heavy chain with the amino acids of SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:
- 9 or SEQ ID NO:10;
- (ii) replacement of the amino acids at EU 160 through 164 of a heavy chain with the amino acids of SEQ ID NO:11, SEQ ID NO:
- 12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, or SEQ ID NO:17;
- (iii) replacement of the amino acids at EU 175 through 177 of a heavy chain with the amino acids of SEQ ID NO:18, SEQ ID NO:19, or NO:20;
- (iv) replacement of the amino acids at EU 190 through 196 of a heavy chain with the amino acids of SEQ ID NO:22, SEQ ID NO:23, or SEQ ID NO:24;
- (v) replacement of the amino acids at EU 264 through 269 of a heavy chain with the amino acids of SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27 or SEQ NO:28;
- (vi) replacement of the amino acids at EU 280 through 284 of a heavy chain with the amino acids of SEQ ID NO:29, SEQ ID NO:30, or SEQ ID NO:31;
- (vii) replacement of the amino acids at EU 292 through 297 of a heavy chain with the amino acids of SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ Id NO:36, SEQ ID NO:37, SEQ ID NO:
- 38, SEQ ID NO:39, SEQ ID NO:40, SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:100, SEQ ID NO:101, SEQ ID NO:102, or SEQ ID NO:103;
- (viii) replacement of the amino acids at EU 314 through 319 of a heavy chain with the amino acids of SEQ ID NO:48, SEQ ID NO:49 or SEQ ID NO:50;
- (ix) replacement of the amino acids at EU 330 through 331 of a heavy chain with the amino acids of SEQ ID NO:51, SEQ ID NO:52, or SEQ ID NO:53;
- (x) replacement of the amino acids at EU 358 through 362 of a heavy chain with the amino acids of SEQ ID NO:54 or SEQ ID NO:55;
- (xi) replacement of the amino acids at EU 384 through 402 of a heavy chain with the amino acids of SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63 or SEQ ID NO:64;
- (xii) replacement of the amino acids at EU 414 through 419 of a heavy chain with the amino acids of SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, or SEQ ID NO:69;
- (xiii) replacement of the amino acids at EU 122 through 126 of a light chain with the amino acids of SEQ ID NO:70, SEQ ID NO:71, or SEQ ID NO:72;
- (xiv) replacement of the amino acids at EU 152 through 155 of a light chain with the amino acids of SEQ ID NO:73, SEQ ID NO:74, or SEQ ID NO:75;
- (xv) replacement of the amino acids at EU 167 through 170 of a light chain with the amino acids of SEQ ID NO:76, SEQ ID NO:
- 77, SEQ ID NO:78, SEQ ID NO:
- 79, SEQ ID NO:81, or SEQ ID NO:82;
- (xvi) replacement of the amino acids at EU 182 through 190 of a light chain with the amino acids of SEQ ID NO:83, SEQ ID NO:84, SEQ ID NO:85, SEQ ID NO:86, or SEQ ID NO:87;
- and
- (xvii) replacement of the amino acids at EU 199 through 204 of a light chain with the amino acids of SEQ ID NO:89, SEQ ID NO:90, SEQ ID NO:91, SEQ ID NO:92, SEQ ID NO:93, SEQ ID NO:94, SEQ ID NO:95, or SEQ ID NO:96.
20 more elements
A conjugate of the formula (IV)
- wherein
- Ab is a full length antibody having a replacement sequence selected from the group consisting of:
- (i) replacement of the amino acids at EU 131 through 135 of a heavy chain with the amino acids of SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:
- 9 or SEQ ID NO:10;
- (ii) replacement of the amino acids at EU 160 through 164 of a heavy chain with the amino acids of SEQ ID NO:11, SEQ ID NO:
- 12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, or SEQ ID NO:17;
- (iii) replacement of the amino acids at EU 175 through 177 of a heavy chain with the amino acids of SEQ ID NO:18, SEQ ID NO:19, or NO:20;
- (iv) replacement of the amino acids at EU 190 through 196 of a heavy chain with the amino acids of SEQ ID NO:22, SEQ ID NO:23, or SEQ ID NO:24;
- (v) replacement of the amino acids at EU 264 through 269 of a heavy chain with the amino acids of SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27 or SEQ NO:28;
- (vi) replacement of the amino acids at EU 280 through 284 of a heavy chain with the amino acids of SEQ ID NO:29, SEQ ID NO:30, or SEQ ID NO:31;
- (vii) replacement of the amino acids at EU 292 through 297 of a heavy chain with the amino acids of SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ Id NO:36, SEQ ID NO:37, SEQ ID NO:
- 38, SEQ ID NO:39, SEQ ID NO:40, SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:100, SEQ ID NO:101, SEQ ID NO:102, or SEQ ID NO:103;
- (viii) replacement of the amino acids at EU 314 through 319 of a heavy chain with the amino acids of SEQ ID NO:48, SEQ ID NO:49 or SEQ ID NO:50;
- (ix) replacement of the amino acids at EU 330 through 331 of a heavy chain with the amino acids of SEQ ID NO:51, SEQ ID NO:52, or SEQ ID NO:53;
- (x) replacement of the amino acids at EU 358 through 362 of a heavy chain with the amino acids of SEQ ID NO:54 or SEQ ID NO:55;
- (xi) replacement of the amino acids at EU 384 through 402 of a heavy chain with the amino acids of SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63 or SEQ ID NO:64;
- (xii) replacement of the amino acids at EU 414 through 419 of a heavy chain with the amino acids of SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, or SEQ ID NO:69;
- (xiii) replacement of the amino acids at EU 122 through 126 of a light chain with the amino acids of SEQ ID NO:70, SEQ ID NO:71, or SEQ ID NO:72;
- (xiv) replacement of the amino acids at EU 152 through 155 of a light chain with the amino acids of SEQ ID NO:73, SEQ ID NO:74, or SEQ ID NO:75;
- (xv) replacement of the amino acids at EU 167 through 170 of a light chain with the amino acids of SEQ ID NO:76, SEQ ID NO:
- 77, SEQ ID NO:78, SEQ ID NO:
- 79, SEQ ID NO:81, or SEQ ID NO:82;
- (xvi) replacement of the amino acids at EU 182 through 190 of a light chain with the amino acids of SEQ ID NO:83, SEQ ID NO:84, SEQ ID NO:85, SEQ ID NO:86, or SEQ ID NO:87;
- and
- (xvii) replacement of the amino acids at EU 199 through 204 of a light chain with the amino acids of SEQ ID NO:89, SEQ ID NO:90, SEQ ID NO:91, SEQ ID NO:92, SEQ ID NO:93, SEQ ID NO:94, SEQ ID NO:95, or SEQ ID NO:96;
- L is a linker moiety bonded to Ab via the amide bond
- to a glutamine in the replacement sequence;
- and
- D is selected from the group consisting of a protein, a radioisotope, an assay agent, and a therapeutic agent.
26 more elements
A method of making an antibody conjugate, comprising the steps of
- (a) mixing a full length antibody with an amine donor compound comprising a primary amine and a moiety selected from the group consisting of a protein, a radioisotope, an assay agent, and a therapeutic agent, in the presence of a transglutaminase;
- the antibody having a replacement sequence selected from the group consisting of
- (i) replacement of the amino acids at EU 131 through 135 of a heavy chain with the amino acids of SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:
- 9 or SEQ ID NO:10;
- (ii) replacement of the amino acids at EU 160 through 164 of a heavy chain with the amino acids of SEQ ID NO:11, SEQ ID NO:
- 12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, or SEQ ID NO:17;
- (iii) replacement of the amino acids at EU 175 through 177 of a heavy chain with the amino acids of SEQ ID NO:18, SEQ ID NO:19, or NO:20;
- (iv) replacement of the amino acids at EU 190 through 196 of a heavy chain with the amino acids of SEQ ID NO:22, SEQ ID NO:23, or SEQ ID NO:24;
- (v) replacement of the amino acids at EU 264 through 269 of a heavy chain with the amino acids of SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27 or SEQ NO:28;
- (vi) replacement of the amino acids at EU 280 through 284 of a heavy chain with the amino acids of SEQ ID NO:29, SEQ ID NO:30, or SEQ ID NO:31;
- (vii) replacement of the amino acids at EU 292 through 297 of a heavy chain with the amino acids of SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ Id NO:36, SEQ ID NO:37, SEQ ID NO:
- 38, SEQ ID NO:39, SEQ ID NO:40, SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:100, SEQ ID NO:101, SEQ ID NO:102, or SEQ ID NO:103;
- (viii) replacement of the amino acids at EU 314 through 319 of a heavy chain with the amino acids of SEQ ID NO:48, SEQ ID NO:49 or SEQ ID NO:50;
- (ix) replacement of the amino acids at EU 330 through 331 of a heavy chain with the amino acids of SEQ ID NO:51, SEQ ID NO:52, or SEQ ID NO:53;
- (x) replacement of the amino acids at EU 358 through 362 of a heavy chain with the amino acids of SEQ ID NO:54 or SEQ ID NO:55;
- (xi) replacement of the amino acids at EU 384 through 402 of a heavy chain with the amino acids of SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63 or SEQ ID NO:64;
- (xii) replacement of the amino acids at EU 414 through 419 of a heavy chain with the amino acids of SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, or SEQ ID NO:69;
- (xiii) replacement of the amino acids at EU 122 through 126 of a light chain with the amino acids of SEQ ID NO:70, SEQ ID NO:71, or SEQ ID NO:72;
- (xiv) replacement of the amino acids at EU 152 through 155 of a light chain with the amino acids of SEQ ID NO:73, SEQ ID NO:74, or SEQ ID NO:75;
- (xv) replacement of the amino acids at EU 167 through 170 of a light chain with the amino acids of SEQ ID NO:76, SEQ ID NO:
- 77, SEQ ID NO:78, SEQ ID NO:
- 79, SEQ ID NO:81, or SEQ ID NO:82;
- (xvi) replacement of the amino acids at EU 182 through 190 of a light chain with the amino acids of SEQ ID NO:83, SEQ ID NO:84, SEQ ID NO:85, SEQ ID NO:86, or SEQ ID NO:87;
- and
- (xvii) replacement of the amino acids at EU 199 through 204 of a light chain with the amino acids of SEQ ID NO:89, SEQ ID NO:90, SEQ ID NO:91, SEQ ID NO:92, SEQ ID NO:93, SEQ ID NO:94, SEQ ID NO:95, or SEQ ID NO:96;
- and
- (b) allowing the transglutaminase to catalyze the formation of an amide bond between the side chain carboxamide of a glutamine of the replacement sequence and the primary amine of the amine donor compound, thereby making the antibody conjugate.
24 more elements
A method of making an antibody conjugate, comprising:
- (a) mixing a full length antibody with a first compound, which first compound is an amine donor compound having a primary amine and a first reactive functional group, in the presence of a transglutaminase;
- the antibody having a replacement sequence selected from the group consisting of
- (i) replacement of the amino acids at EU 131 through 135 of a heavy chain with the amino acids of SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:
- 9 or SEQ ID NO:10;
- (ii) replacement of the amino acids at EU 160 through 164 of a heavy chain with the amino acids of SEQ ID NO:11, SEQ ID NO:
- 12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, or SEQ ID NO:17;
- (iii) replacement of the amino acids at EU 175 through 177 of a heavy chain with the amino acids of SEQ ID NO:18, SEQ ID NO:19, or NO:20;
- (iv) replacement of the amino acids at EU 190 through 196 of a heavy chain with the amino acids of SEQ ID NO:22, SEQ ID NO:23, or SEQ ID NO:24;
- (v) replacement of the amino acids at EU 264 through 269 of a heavy chain with the amino acids of SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27 or SEQ NO:28;
- (vi) replacement of the amino acids at EU 280 through 284 of a heavy chain with the amino acids of SEQ ID NO:29, SEQ ID NO:30, or SEQ ID NO:31;
- (vii) replacement of the amino acids at EU 292 through 297 of a heavy chain with the amino acids of SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ Id NO:36, SEQ ID NO:37, SEQ ID NO:
- 38, SEQ ID NO:39, SEQ ID NO:40, SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:100, SEQ ID NO:101, SEQ ID NO:102, or SEQ ID NO:103;
- (viii) replacement of the amino acids at EU 314 through 319 of a heavy chain with the amino acids of SEQ ID NO:48, SEQ ID NO:49 or SEQ ID NO:50;
- (ix) replacement of the amino acids at EU 330 through 331 of a heavy chain with the amino acids of SEQ ID NO:51, SEQ ID NO:52, or SEQ ID NO:53;
- (x) replacement of the amino acids at EU 358 through 362 of a heavy chain with the amino acids of SEQ ID NO:54 or SEQ ID NO:55;
- (xi) replacement of the amino acids at EU 384 through 402 of a heavy chain with the amino acids of SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63 or SEQ ID NO:64;
- (xii) replacement of the amino acids at EU 414 through 419 of a heavy chain with the amino acids of SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, or SEQ ID NO:69;
- (xiii) replacement of the amino acids at EU 122 through 126 of a light chain with the amino acids of SEQ ID NO:70, SEQ ID NO:71, or SEQ ID NO:72;
- (xiv) replacement of the amino acids at EU 152 through 155 of a light chain with the amino acids of SEQ ID NO:73, SEQ ID NO:74, or SEQ ID NO:75;
- (xv) replacement of the amino acids at EU 167 through 170 of a light chain with the amino acids of SEQ ID NO:76, SEQ ID NO:
- 77, SEQ ID NO:78, SEQ ID NO:
- 79, SEQ ID NO:81, or SEQ ID NO:82;
- (xvi) replacement of the amino acids at EU 182 through 190 of a light chain with the amino acids of SEQ ID NO:83, SEQ ID NO:84, SEQ ID NO:85, SEQ ID NO:86, or SEQ ID NO:87;
- and
- (xvii) replacement of the amino acids at EU 199 through 204 of a light chain with the amino acids of SEQ ID NO:89, SEQ ID NO:90, SEQ ID NO:91, SEQ ID NO:92, SEQ ID NO:93, SEQ ID NO:94, SEQ ID NO:95, or SEQ ID NO:96;
- (b) allowing the transglutaminase to catalyze the formation of an amide bond between the side chain carboxamide of a glutamine of the replacement sequence and the primary amine of the first compound, to make an adduct of the antibody and the first compound;
- (c) contacting the adduct with a second compound having a second reactive functional group and a moiety selected from the group consisting of a protein, a radioisotope, an assay agent, and a therapeutic agent;
- the second reactive functional group being capable of reacting with the first reactive functional group to form a covalent bond therebetween;
- and
- (d) allowing the first and second reactive functional groups to react and form a covalent bond therebetween, thereby making the antibody conjugate.
27 more elements
Dependencies are inferred from the claim text.